icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
XEzC9WULGX5CBZzZ